TrialResults - center   -  Clinical trials results database in cardiology

GAMMA

You are here:  Home > New trials (ongoing)

Ongoing or excluded trials recently added

24/08/2010 - DEFINE  -  versus

  cardiovascular prevention - CEPT inhibition - all type of patients

07/08/2010 - FAVORIT  -  lowering homocysteine levels with a multivitamin versus placebo

  cardiovascular prevention - plasma homocysteine lowering intervention - all type of patients

07/08/2010 - CSPPT  -  enalapril 10 mg / folic acid 0.8 mg daily versus Enalapril maleate 10 mg daily

  cardiovascular prevention - plasma homocysteine lowering intervention - all type of patients

07/08/2010 - SU.FOL.OM3  -  supplementation with natural foLate, vitamin B6 and B12 and/or omega-3 fatty acids versus placebo

  cardiovascular prevention - plasma homocysteine lowering intervention - all type of patients

18/06/2010 - PC-Trial  -  Percutaneous closure of patent foramen ovale (AMPLATZER® PFO Occluder) versus antitrhombotic treatment

  post stroke - foramen ovale closure - all type of patients

18/06/2010 - REDUCE  -  GORE HELEX™ Septal Occluder plus antiplatelet versus antiplatelet medical management alone

  post stroke - foramen ovale closure - all type of patients

22/05/2010 - NCT00603590  -  fixed-dose combination therapy with two antihypertensive drugs, aspirin and atorvastatin versus placebo

  cardiovascular prevention - polypill - all type of patients

22/04/2010 - TIDE  -  pioglitazone or rosiglitazone versus placebo

  diabetes - antidiabetic drugs - type 2 diabetes (NIDD)

  diabetes - glitazone - all type of patients

  diabetes - glitazone - patients with cardiovascular disease

  diabetes - insulin sensitizer - all type of patients

  diabetes - insulin sensitizer - patients with cardiovascular disease

15/04/2010 - ZETELD  -  ezetimibe 10 mg plus atorvastatin 10 mg for 12 weeks versus up titration to atorvastatin 20 mg for 6 weeks followed by up titration to atorvastatin 40 mg for an additional 6 weeks

  cardiovascular prevention - cholesterol lowering intervention - high risk patients with or without LDL cholesterol elevation

  cardiovascular prevention - cholesterol lowering intervention - all chronical situations

05/04/2010 - JPPP  -  aspirin versus no aspirin

  cardiovascular prevention - antiplatelets drug - all type of patients

  cardiovascular prevention - antithrombotics - primary prevention

05/04/2010 - ACAPULCO  -  versus

  acute coronary syndrome - antithrombotics - all type of patient

  acute coronary syndrome - antiplatelets drug - all type of patients

21/03/2010 - RAS  -  right internal thoracic artery or radial artery graft as second graft versus saphenous vein graft as second graft.

  CABG surgery - radial graft - all type of patients

16/03/2010 - GRAVITAS  -  versus

  stent - antithrombotics - all type of patients

  percutaneous coronary intervention - antithrombotics - PCI with stent placement

16/03/2010 - ARTIC adjusted  -  versus

  stent - antithrombotics - all type of patients

  percutaneous coronary intervention - antithrombotics - PCI with stent placement

16/03/2010 - ARTIC (extended dual antiplatelet)  -  Pursuit of a dual oral antiplatelet therapy (aspirin and clopidogrel) beyond one year versus Interruption of clopidogrel therapy after one year

  stent - antithrombotics - all type of patients

  percutaneous coronary intervention - antithrombotics - PCI with stent placement

14/03/2010 - NCT00320398  -  Fondaparinux versus

  DVT prophylaxis - antithrombotics - orthopedic surgery

  DVT prophylaxis - antithrombotics - elective hip replacement

  DVT prophylaxis - pentasaccharide - all type of patients

13/03/2010 - FONDACAST  -  subcutaneously, once daily, fondaparinux 2.5 mg for at least 21 Days, up to complete mobilization, with a maximal duration of treatment of 45 days versus daily nadroparin 2850 anti-Xa IU (0.3 mL) for at least 21 Days, up to complete mobilization

  DVT prophylaxis - antithrombotics - patients with immobilization of the lower extremities

13/03/2010 - NCT00333021  -  Fondaparinux versus

  DVT prophylaxis - antithrombotics - abdominal surgery

  DVT prophylaxis - pentasaccharide - abdominal surgery

  DVT prophylaxis - pentasaccharide - all type of patients

03/03/2010 - TRA 2P -TIMI 50  -  SCH 530348 2.5 mg daily versus placebo

  cardiovascular prevention - antiplatelets drug - all type of patients

  cardiovascular prevention - antiplatelets drug - secondary prevention in patients with intermittent claudication

  cardiovascular prevention - antiplatelets drug - secondary prevention in patients with CAD

29/01/2010 - CABANA  -  left atrial catheter ablation versus current state-of-the-art therapy with either rate control or rhythm control drugs

  atrial fibrillation - catheter ablation - all type of patients

16/01/2010 - B0661004  -  Apixaban 2.5 or 5 mg twice daily versus placebo

  acute coronary syndrome - antithrombotics - all type of patient

  acute coronary syndrome - anticoagulant - All ACS (including AMI)

  acute coronary syndrome - direct factor Xa inhibitors - all type of patients

  acute coronary syndrome - antithrombotics - patients with a recent ACS

16/01/2010 - APPRAISE 2 (CV185-068)  -  apixaban 5mg twice daily versus placebo

  acute coronary syndrome - antithrombotics - all type of patient

  acute coronary syndrome - anticoagulant - All ACS (including AMI)

  acute coronary syndrome - direct factor Xa inhibitors - all type of patients

  acute coronary syndrome - antithrombotics - patients with a recent ACS

16/01/2010 - ARISTOTLE (CV185-030)  -  apixaban 5mg twice daily versus warfarin adjusted for an INR between 2 and 3

  atrial fibrillation - antithrombotics - primary prevention of thromboembolic events

  atrial fibrillation - direct factor Xa inhibitors - all type of patients

  atrial fibrillation - new oral anticoagulant - all type of patients

16/01/2010 - B0661003  -  apixaban 5 or 2.5 mg twice daily versus warfarin

  atrial fibrillation - antithrombotics - primary prevention of thromboembolic events

  atrial fibrillation - direct factor Xa inhibitors - all type of patients

  atrial fibrillation - new oral anticoagulant - all type of patients

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2010/9 23 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar